Literature DB >> 32990089

Neuromyelitis optica spectrum disorder secondary to COVID-19.

Victoria C Shaw1, Gurvin Chander2, Amar Puttanna2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32990089     DOI： 10.12968/hmed.2020.0401

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN： 1750-8460            Impact factor:   0.825


× No keyword cloud information.
  6 in total

Review 1.  COVID-19-Associated Myelitis Involving the Dorsal and Lateral White Matter Tracts: A Case Series and Review of the Literature.

Authors:  H Y Huang; L M Shah; J S McNally; T Sant; T A Hutchins; E D Goldstein; M E Peckham
Journal:  AJNR Am J Neuroradiol       Date:  2021-08-19       Impact factor: 4.966

Review 2.  COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2.

Authors:  Ariane Lewis; Rajan Jain; Jennifer Frontera; Dimitris G Placantonakis; Steven Galetta; Laura Balcer; Kara R Melmed
Journal:  J Neuroimaging       Date:  2021-06-08       Impact factor: 2.324

Review 3.  Cerebrospinal fluid in COVID-19: A systematic review of the literature.

Authors:  Ariane Lewis; Jennifer Frontera; Dimitris G Placantonakis; Jennifer Lighter; Steven Galetta; Laura Balcer; Kara R Melmed
Journal:  J Neurol Sci       Date:  2021-01-10       Impact factor: 3.181

4.  Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review.

Authors:  Luis Alberto Rodríguez de Antonio; Inés González-Suárez; Inés Fernández-Barriuso; María Rabasa Pérez
Journal:  Mult Scler Relat Disord       Date:  2021-01-21       Impact factor: 4.339

5.  Optic neuritis following SARS-CoV-2 infection.

Authors:  Mónica Saray Rodríguez-Rodríguez; Rosa María Romero-Castro; Claudia Alvarado-de la Barrera; María Gabriela González-Cannata; Ana Karen García-Morales; Santiago Ávila-Ríos
Journal:  J Neurovirol       Date:  2021-03-23       Impact factor: 2.643

6.  COVID-19 and the risk of CNS demyelinating diseases: A systematic review.

Authors:  Itay Lotan; Shuhei Nishiyama; Giovanna S Manzano; Melissa Lydston; Michael Levy
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.